NeoCannBio
Latest round
- Series B
Last raised
- Sep 2023
Total raised
- $11M
Investors
- 11
About NeoCannBio
, Ltd. operates as a medical cannabis company that specializes in raw material drug development and cannabis ingredient extraction using its technology., Ltd. develops various cannabinoid raw materials using only selected parts of the hemp metabolic pathway or microorganism-derived enzymes, as well as natural molecules. The company's microwave processing technology and equipment manufacturing patent extract and simultaneously obtain decarbonated processed products. It provides a standardized content analysis service. In addition, the company is also engaged in developing new drugs that can overcome intractable diseases and diseases caused by aging.
Who invested in NeoCannBio
11 investors across 3 rounds
See all investors in NeoCannBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NeoCannBio
Who invested in NeoCannBio?
NeoCannBio has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NeoCannBio raised?
NeoCannBio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did NeoCannBio last raise money?
NeoCannBio's most recent round on record is a Series B, in Sep 2023.
What does NeoCannBio do?
NeoCannBio is a healthcare company.
Where is NeoCannBio headquartered?
NeoCannBio is headquartered in Seoul, South Korea.
Which VCs invest in companies like NeoCannBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Hengxu Capital and Riverhead Capital back healthcare companies at NeoCannBio's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like NeoCannBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.